10x Genomics, Inc. Class A Common Stock TXG
$76.60
-0.48%
at last close
Financials (TTM)
- Revenue
- $616.91 million
- Net Income
- $-75,125,000
- Net Margin
- -12.18%
- Return on Equity
- -9.10%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 12.15
- Price / Sales
- 16.26
Over the trailing twelve months, 10x Genomics, Inc. Class A Common Stock generated revenue of $616.91 million and net income of $-75,125,000, a net margin of -12.18%.
At the last closing price of $76.60, TXG trades at 16.26 times sales, with a market capitalization of $10.03 billion.
Key Stats
- Last Close
- $76.60
- Market Cap
- $10.03 billion
- 52-Week Range
- $11.16 – $79.94
- Average Volume
- 3.04 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.